Keyword [Tkis] Result: 181 - 200 | Page: 10 of 10 181.  Study On The Relationship Between The Expression Level Of MiR-221 In Peripheral Blood And The Acquired Resistance Of The First Generation Of EGFR-TKIs In Lung Cancer 182.  The Effect Of Concurrent TP53 Mutations On Clinical Efficacy Of First-generation EGFR-TKIs In Patients With EGFR-mutated Advanced NSCLC 183.  Association Of Gut Microbiota And EGFR-TKIs-Related Skin Rash In Non-small Cell Lung Cancer 184.  Bevacizumab Plus EGFR-TKI Combination After Acquired Resistance To Tkis In T790M(-)EGFR-sensitive Mutations NSCLC Patients: A Single Arm Observational Study 185.  Prognostic Value Of BCR-ABL And Clinical Significance Of ABL Kinase Domain Mutation After TKIs 186.  The Efficacy Observation Of EGFR-TKIs Combined With Apatinib For Non-small-cell Lung Cancer Patients With Acquired Resistance To Original EGFR-TKIs 187.  The Prognostic Value Of Platelet Count In The Treatment Of Non-small Cell Lung Cancer Patients With EGFR-TKIs 188.  Effect Of Silencing FGL1 On Sensitivity Of Gefitinib In Lung Adenocarcinoma Cells 189.  Analysis Of Clinicopathological Features Of EGFR Uncommon Mutations And Comparison Of First-line TKIs And Chemotherapy Efficacy 190.  Synergistic Effect Of Elemene Combined With First-generation EGFR-TKIs In The Treatment Of Advanced Lung Adenocarcinoma 191.  Study Of A Novel Estrogen Receptor GPER1 In The Proliferation Of EGFR-TKIs Resistant Lung Cancer Cells 192.  Efficacy And Mechanism Of Acquired Resistance Of The Second-Generation EGFR-TKIs In Advanced NSCLC With HER2 Mutation 193.  A Retrospective Analysis Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors (EGFR-TKIs) With Or Without Chemotherapy For Advanced Lung Adenocarcinoma 194.  Detection Of Multi-driver Gene And TP53 Gene In Peripheral Blood Of Patients With Advanced Non-small Cell Lung Cancer And Prognostic Effects Of Gene Co-mutation 195.  Analysis Of The Efficacy And Related Factors Of Osimertinib After The First Generation EGFR-TKIs In Advanced Lung Adenocarcinoma With T790M Positive 196.  Protective Effect Of PI3K On Cardiotoxicity Induced By Tyrosine Kinase Inhibitors 197.  EGFR Mutations In Patients With Advanced NSCLC Complicated With COPD And The Response And Prognosis Of EGFR-TKIs Treatment 198.  Observation On The Efficacy Of Three Treatment Options For T790M Negative Advanced NSCLC Patients After First Generation EGFR-TKIs Resistance 199.  The Anti-NSCLC Activity And Mechanism Of Shikonin Combined With EGFR-TKIs 200.  Clinical Observation Of Self-made Yangyin Zhixie Decoction Combined With Navel Therapy In The Treatment Of EGFR-TKIs-related Diarrhea   <<First  <Prev  Next>  Last>>  Jump to

Globe Thesis Copyright © 2023. All Rights Reserved. | Privacy | Copyright | Contribute | About | Contact | RSS